These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 18990451

  • 1. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel.
    Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD.
    J Infect; 2008 Dec; 57(6):441-8. PubMed ID: 18990451
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A, Spanish Network for Research in Infectious Diseases (REIPI).
    Clin Infect Dis; 2010 Jan 01; 50(1):40-8. PubMed ID: 19995215
    [Abstract] [Full Text] [Related]

  • 5. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH.
    Microb Drug Resist; 2011 Dec 01; 17(4):537-44. PubMed ID: 21875342
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY, Korean Network for Study of Infectious Diseases (KONSID).
    Int J Antimicrob Agents; 2010 Sep 01; 36(3):284-7. PubMed ID: 20580534
    [Abstract] [Full Text] [Related]

  • 7. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.
    J Antimicrob Chemother; 2009 Apr 01; 63(4):781-4. PubMed ID: 19223299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.
    Arch Intern Med; 2008 Sep 22; 168(17):1897-902. PubMed ID: 18809817
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 22; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 15. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
    Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H.
    J Hosp Infect; 2008 Apr 22; 68(4):355-62. PubMed ID: 18353497
    [Abstract] [Full Text] [Related]

  • 16. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.
    Pitout JD, Hanson ND, Church DL, Laupland KB.
    Clin Infect Dis; 2004 Jun 15; 38(12):1736-41. PubMed ID: 15227620
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
    Tian SF, Chen BY, Chu YZ, Wang S.
    Can J Microbiol; 2008 Sep 15; 54(9):781-5. PubMed ID: 18772941
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.
    Anunnatsiri S, Towiwat P, Chaimanee P.
    Southeast Asian J Trop Med Public Health; 2012 Sep 15; 43(5):1169-77. PubMed ID: 23431823
    [Abstract] [Full Text] [Related]

  • 19. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.
    J Hosp Infect; 2008 Feb 15; 68(2):116-22. PubMed ID: 18226420
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb 15; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.